An observational, prospective study to assess the use, effectiveness, and safety of voxelotor in patients with sickle cell disease (SCD) in a real-life setting (VoxEval)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

  Effectiveness study (incl. comparative)

  Safety study (incl. comparative)

Study drug and medical condition

• Medicinal product name:
  OXBRYTA
• Study drug International non-proprietary name (INN) or common name:
  VOXELOTOR
• Anatomical Therapeutic Chemical (ATC) code:
  (B06AX03) voxelotor

  voxelotor
• Medical condition to be studied:
  Sickle cell disease